Clinical Validation of the Modified (mHam)2.0 Test to Aid the Diagnosis & Treatment of Complement-Mediated Diseases
Time: 9:30 am
day: Conference Day One
Details:
- Introducing mHam 2.0, a novel cell-based clinical assay for diagnosing and treating complement-mediated diseases
- How using the mHam 2.0 can help develop and evaluate new complement drug candidates or optimize clinical trial subject recruitment
